Guangzhou Baiyun Mountain Scenic Area Administration Fined 850,000 Yuan for 27 Illegal Constructions

JPMorgan Increases Stake in BAIYUNSHAN PH (00874) by 220,000 Shares at HK$18.92 per Share

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. Announces Date for Third Extraordinary General Meeting in 2025

BRIEF-Guangzhou Baiyunshan Pharmaceutical Says GP Corp. Would Sell Accounts Receivable To Administrator

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Plans to Launch Accounts Receivable Securitization Business

Guangzhou Baiyunshan Pharmaceutical - Gp Corp. Would Sell Accounts Receivable to Administrator

Guangzhou Baiyunshan Pharmaceutical - Would Establish Special Scheme for Issuance of Asset-Backed Securities in Aggregate of No More Than RMB3 Bln

Guangzhou Baiyunshan Pharmaceutical Launches RMB3 Billion Asset-Backed Securities Offering

BAIYUNSHAN PH (00874) Sells Fifth Batch of Additional Underlying Assets to Xingzheng Asset Management

BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office

Guangzhou Baiyunshan Pharmaceutical - Guanghua Entered in Land Reserve Compensation Agreement With Tonghe Sub-District Office

Guangzhou Baiyunshan Pharmaceutical - Total Amount of Compensation and Incentive RMB448.6 Mln

Guangzhou Baiyunshan Pharmaceutical Signs Land Reserve Compensation Agreement

Baiyunshan Pharmaceutical's Unit Gets Registration Certificate From Vietnam for Angong Niuhuang Pills

Baiyunshan Pharma Gets Regulatory Nod to Acquire Stake in Nanjing Pharma

JPMorgan Increases Stake in BAIYUNSHAN PH by Approximately 267,200 Shares at HK$18.90 per Share

JPMorgan Increases Stake in BAIYUNSHAN PH (00874) by Approximately 267,200 Shares at HK$18.9 per Share

BAIYUNSHAN PH (00874) Rises Over 4% Post-Earnings; Q1-Q3 Net Profit Hits RMB3.31B as Wanglaoji International Cans Debut in Middle East

BAIYUNSHAN PH (00874) Reports Q3 Results: Net Profit Rises 4.78% YoY to RMB3.31 Billion

BRIEF-Guangzhou Baiyunshan Pharmaceutical Q3 Net Profit Up 30.3% Y/Y